Literature DB >> 6791574

Chronic GM1 gangliosidosis presenting as dystonia: I. Clinical and pathological features.

J E Goldman, D Katz, I Rapin, D P Purpura, K Suzuki.   

Abstract

Clinical and pathological studies are reported from investigation of a 27-year-old man with GM1 gangliosidosis who experienced a slowly progressive dystonia that began about age 4, primarily affected the face and limbs, and eventually became almost totally incapacitating. There was only mild intellectual deterioration; myoclonus, seizures, and macular cherry-red spots were never observed. Postmortem examination revealed intraneuronal storage, localized predominantly to the basal ganglia, in which neurons contained round, multilamellated inclusions. Golgi studies revealed meganeurites arising from medium spiny neurons. Other areas of the central nervous system appeared relatively unaffected, although small basilar dilatations were observed in scattered cortical pyramidal neurons and Purkinje cell dendrites showed focal swellings. Vacuolated cells of the reticuloendothelial system were observed, including Kupffer cells and histiocytes in the spleen, marrow, and intestinal tract. Biochemical analysis revealed a generalized beta-galactosidase deficiency with specific accumulation of GM1 ganglioside in the basal ganglia.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6791574     DOI: 10.1002/ana.410090509

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  13 in total

1.  Hallervorden-Spatz disease: clinical and MRI study of 11 cases diagnosed in life.

Authors:  L Angelini; N Nardocci; V Rumi; C Zorzi; L Strada; M Savoiardo
Journal:  J Neurol       Date:  1992-10       Impact factor: 4.849

2.  Comments on "type 3 GM1 gangliosidosis: clinical and neuroradiological findings in an 11-year-old girl".

Authors:  E Uyama; M Uchino; M Ando
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

3.  Demonstration of GM1-ganglioside in nervous system in generalized GM1-gangliosidosis using cholera toxin B subunit.

Authors:  T Iwamasa; T Ohshita; K Nashiro; M Iwanaga
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

4.  Hemidystonia: a report of 22 patients and a review of the literature.

Authors:  L C Pettigrew; J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-07       Impact factor: 10.154

Review 5.  Modeling neuronopathic storage diseases with patient-derived culture systems.

Authors:  Friederike Zunke; Joseph R Mazzulli
Journal:  Neurobiol Dis       Date:  2019-02-19       Impact factor: 5.996

6.  A case of chronic GM1 gangliosidosis presenting as dystonia: clinical and biochemical studies.

Authors:  K Inui; R Namba; Y Ihara; K Nobukuni; M Taniike; M Midorikawa; H Tsukamoto; S Okada
Journal:  J Neurol       Date:  1990-12       Impact factor: 4.849

7.  Type 3 GM1 gangliosidosis: clinical and neuroradiological findings in an 11-year-old girl.

Authors:  R Tanaka; T Momoi; A Yoshida; M Okumura; S Yamakura; Y Takasaki; T Kiyomasu; C Yamanaka
Journal:  J Neurol       Date:  1995-05       Impact factor: 4.849

8.  Mutations in the lysosomal beta-galactosidase gene that cause the adult form of GM1 gangliosidosis.

Authors:  S Chakraborty; M A Rafi; D A Wenger
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

9.  Inheritance of idiopathic torsion dystonia among Jews.

Authors:  N Zilber; A D Korczyn; E Kahana; K Fried; M Alter
Journal:  J Med Genet       Date:  1984-02       Impact factor: 6.318

10.  GM1 gangliosidosis, type 2: ocular clinicopathologic correlation.

Authors:  L J Cairns; W R Green; H S Singer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1984       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.